ASTS
AST SpaceMobile, Inc.
ASTS has the edge over IMMR overall, supported by stronger valuation and stronger modeled upside.
IMMR
Immersion Corporation
IMMR has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
IMMR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
IMMR's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
IMMR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.8x | $0.95 | -86% |
| Fair | 7.4x | $2.51 | -64% |
| Expensive | 20x | $6.92 | -0.7% |
| Current | 21x | $6.97 | — |
Historical ranges are pointers, not guarantees.
IMMR's PE is in its expensive range at 21x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
IMMR Forward outlook
There aren't enough analyst estimates for IMMR to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
IMMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | -51% |
| Q1 2024 | $1.38 | +35% |
| Q4 2023 | $1.04 | +13% |
| Q3 2023 | $1.13 | +214% |
| Q2 2023 | $1.28 | +412% |
| Q1 2023 | $1.02 | +117% |
| Q4 2022 | $0.92 | +136% |
| Q3 2022 | $0.36 | -43% |
IMMR has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over IMMR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
IMMR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $294.4M | +0.8% |
| Q2 2026 | $270M | -5.2% |
| Q1 2026 | $518.5M | +9.2% |
| Q4 2025 | $650.2M | +5.5% |
| Q3 2025 | $292M | +194% |
| Q2 2025 | $284.9M | +522% |
| Q1 2025 | $474.8M | +4474% |
| Q4 2024 | $616.2M | +6399% |
IMMR's revenue has held roughly level: $294M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.8% | +2.2 points |
| Q2 2026 | 2.7% | +3.1 points |
| Q1 2026 | 1% | -4.6 points |
| Q4 2025 | 6.2% | -4.3 points |
| Q3 2025 | -9% | -35 points |
| Q2 2025 | -0.4% | -35 points |
| Q1 2025 | 5.5% | -32 points |
| Q4 2024 | 10% | -38 points |
IMMR has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
IMMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.1M | +$18.3M |
| Q2 2026 | $79.4M | +69% |
| Q1 2026 | -$37.5M | +$8.8M |
| Q2 2025 | $47M | +49% |
| Q1 2025 | -$46.2M | -691% |
| Q2 2024 | $31.6M | +797% |
| Q1 2024 | $29.9M | +749% |
| Q4 2023 | $7.8M | -3% |
IMMR has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
IMMR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +176K shares |
| 1 year | +2.1% | +688K shares |
| 3 years | +1.7% | +553K shares |
| 5 years | +6.6% | +2.1M shares |
| Available history | +4.4% | +1.4M shares |
IMMR has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | $2.1M |
| Q3 2023 | $3.3M |
| Q2 2023 | $2.9M |
| Q1 2023 | — |
| Q4 2022 | $2M |
| Q3 2022 | $5.2M |
| Q2 2022 | $1.6M |
| Q1 2022 | $4.4M |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IMMR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q1 2024 | -2.9x | Net Cash |
| Q4 2023 | -3.1x | Net Cash |
| Q3 2023 | -1.5x | Net Cash |
| Q2 2022 | -3.2x | Net Cash |
IMMR has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
IMMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 26.0 | Neutral |
IMMR's weekly RSI is 49 (neutral) and its Stochastic is 26 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
IMMR PE vs Technology Sector
| Metric | IMMR | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 84 | 35 | 49 pts above |
IMMR is trading at 21x earnings, a 26% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
IMMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.14 | 2.4% below |
| 20 week MA | $7.20 | 3.2% below |
| 50 week MA | $6.70 | 4% above |
| 100 week MA | $7.11 | 2% below |
| 200 week MA | $7.51 | 7.2% below |
IMMR's trend is mixed: it's above one of its five weekly moving averages, and 7.2% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
IMMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.58 | $8.93 | +18% |
| 2021 | $8.93 | $6.10 | -32% |
| 2022 | $6.10 | $7.33 | +20% |
| 2023 | $7.33 | $7.06 | -3.7% |
| 2024 | $7.06 | $9.00 | +27% |
| 2025 | $9.00 | $6.85 | -24% |
| 2026 YTD | $6.85 | $6.97 | +1.8% |
IMMR has the edge over ASTS on returns for 2026, with the stronger performance.